フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Glancy Binkow & Goldberg LLP announces that all persons or entities who purchased the securities of K-V Pharmaceutical Company...
Law Offices of Howard G. Smith, representing investors of K-V Pharmaceutical Company (“K-V" or the “Company”) (NYSE:KV-A...
Notice is hereby given that Glancy Binkow & Goldberg LLP has filed a class action lawsuit in the United States District Court for...
Faruqi & Faruqi, LLP, a national law firm concentrating on investor rights, consumer rights and enforcement of federal antitrust...
Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, and the...
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of purchasers of the common stock...
Zeldes & Haeggquist, LLP, a shareholder and consumer rights litigation firm, has commenced an investigation into possible...
K-V Pharmaceutical Company Announces Filing of Fiscal 2011 Form 10-K and Schedules Investor Conference Call PR Newswire ST. LOUIS, June 13, 2011...
K-V Pharmaceutical Company Announces $200 Million Private Debt Offering PR Newswire ST. LOUIS, March 1, 2011 ST. LOUIS, March 1, 2011...
KV Pharmaceutical Company Announces Delay In Conference Call and Provides Overview Of Conference Call Comments PR Newswire ST. LOUIS, Feb. 14...
K-V Pharmaceutical Company Announces Reliance on the Financial Distress Exception to NYSE's Shareholder Approval Policy to Issue Warrants in...
K-V Pharmaceutical Company Announces Completion of a $32 Million Private Placement of Class A Common Stock COMPANY ANNOUNCES AGREEMENT OF TERMS...
K-V Pharmaceutical Company to Host Investor Conference Call on February 14, 2011 PR Newswire ST. LOUIS, Feb. 4, 2011 ST. LOUIS, Feb. 4, 2011...
K-V Pharmaceutical Company Updates Status of New Drug Application for Gestiva™ PR Newswire ST. LOUIS, Jan. 12, 2011 ST. LOUIS, Jan. 12, 2011...
ST. LOUIS, Feb. 25 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE:KVa/KVb) ("the Company") today announced that it has reached an...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約